Tony Butler
Stock Analyst at Rodman & Renshaw
(0.57)
# 4,145
Out of 5,129 analysts
88
Total ratings
27.38%
Success rate
-22.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $4.59 | +444.66% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $1.29 | +752.71% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.31 | +1,274.05% | 4 | Sep 26, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $1.79 | +793.85% | 5 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.17 | +754.70% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $48.32 | +55.22% | 8 | Aug 8, 2023 | |
| GTBP GT Biopharma | Reiterates: Hold | $60 | $0.47 | +12,638.85% | 5 | Aug 7, 2023 | |
| CGEN Compugen | Reiterates: Buy | $13 | $1.71 | +660.23% | 6 | Aug 7, 2023 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $50 | $5.53 | +804.98% | 5 | Aug 3, 2023 | |
| ALLO Allogene Therapeutics | Reiterates: Buy | $15 | $1.65 | +809.09% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.18 | +13,450.14% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.35 | +1,011.11% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.86 | +105.76% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $0.70 | +2,339.02% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $2.98 | +5,470.47% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $7.76 | +673.20% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $1.99 | +11,960.30% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.22 | +2,577.38% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $0.99 | +36,256.29% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $2.19 | -8.68% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.88 | +1,604.55% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.46 | +584.93% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $6.44 | +132.92% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $12.00 | +816.67% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $12.50 | +7,580.00% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $4.59
Upside: +444.66%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $1.29
Upside: +752.71%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.31
Upside: +1,274.05%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $1.79
Upside: +793.85%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.17
Upside: +754.70%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $48.32
Upside: +55.22%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.47
Upside: +12,638.85%
Compugen
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.71
Upside: +660.23%
Bicycle Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $5.53
Upside: +804.98%
Allogene Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.65
Upside: +809.09%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.18
Upside: +13,450.14%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.35
Upside: +1,011.11%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $4.86
Upside: +105.76%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $0.70
Upside: +2,339.02%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $2.98
Upside: +5,470.47%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $7.76
Upside: +673.20%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $1.99
Upside: +11,960.30%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.22
Upside: +2,577.38%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $0.99
Upside: +36,256.29%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $2.19
Upside: -8.68%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $0.88
Upside: +1,604.55%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.46
Upside: +584.93%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $6.44
Upside: +132.92%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $12.00
Upside: +816.67%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $12.50
Upside: +7,580.00%